Browsing by Author Gong, Lizhong
Showing results 1 to 5 of 5
| Issue Date |
Title |
Author(s) |
| Jan-2021 |
Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center |
Duan, Wenbing;Liu, Xiaohong;Zhao, Xiaosu;Jia, Jinsong;Wang, Jing;Gong, Lizhong;Jiang, Qian;Zhao, Ting;Wang, Yu;Zhang, Xiaohui;Xu, Lanping;Shi, Hongxia;Chang, Yingjun;Liu, Kaiyan;Huang, Xiaojun;Qin, Yazhen;Jiang, Hao |
| Feb-2020 |
Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA |
Wang, Jing;Lu, RunQing;Wu, Ying;Jia, JinSong;Gong, Lizhong;Liu, XiaoHong;Lu, ShengYe;Wang, Yu;Yan, ChenHua;Liu, KaiYan;Zhang, XiaoHui;Xu, LanPing;Jiang, Qian;Zhao, XiaoSu;Shi, HongXia;Lai, YueYun;Huang, XiaoJun;Ruan, GuoRui;Jiang, Hao |
| 15-Nov-2022 |
Interferon-alpha-2b As a Maintenance Therapy Gain a High Rate of MRD Negative Conversion and Improve RFS in Patients with Favorable-Risk Acute Myeloid Leukemia-a Prospective, Single-Arm Study |
Liu, Xiaohong;Li, Yao;Yu, Wenjing;Zhu, Xiaolu;Jia, Jinsong;Gong, Lizhong;Zhao, Xiaosu;Chang, Yingjun;Huang, Xiao-Jun;Jiang, Hao |
| Jan-2021 |
The loss or absence of minimal residual disease of <0 center dot 1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis |
Duan, Wenbing;Liu, Xiaohong;Jia, Jinsong;Wang, Jing;Gong, Lizhong;Jiang, Qian;Zhao, Ting;Wang, Yu;Zhang, Xiaohui;Xu, Lanping;Zhao, Xiaosu;Qin, Yazhen;Shi, Hongxia;Chang, Yingjun;Huang, Xiaojun;Jiang, Hao |
| 23-Nov-2021 |
Safety and Short-Term Efficacy of Venetoclax Combined with Azacitidine in Acute Myeloid Leukemia: A Single Institution Experience |
Yu, Wen-Jing;Jia, Jinsong;Wang, Jing;Tang, Fei-Fei;Gong, Lizhong;Liu, Xiaohong;Zhu, Xiaolu;Zhao, Xiaosu;Huang, Xiao Jun;Jiang, Hao |
